Moxydar

Aluminium oxide, hydrated, the active ingredient in Moxydar, is an antacid presented as an oral dosage form for oral use. It helps relieve heartburn, dyspepsia and other symptoms of excess gastric acidity in adults and adolescents. GNH USA supplies Moxydar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moxydar is an antacid that acts on excess gastric acid to alleviate discomfort associated with several gastrointestinal conditions. - Heartburn: provides rapid symptomatic relief by neutralising stomach acid. - Dyspepsia: reduces acidity‑related bloating and upper abdominal pain. - Acid indigestion: eases burning sensations after meals. - Gastric hyperacidity: helps maintain a healthier gastric pH balance.

Moxydar may cause adverse reactions, most of which are mild and transient.

Common Side Effects: - Constipation: mild to moderate difficulty passing stool. - Flatulence: increased intestinal gas. - Nausea: feeling of unease or urge to vomit. - Belching: frequent release of gas from the stomach. - Mild abdominal discomfort: occasional stomach cramps. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Hypermagnesemia: elevated magnesium levels, especially in renal impairment. - Metabolic alkalosis: excessive rise in blood pH. - Severe constipation leading to bowel obstruction. - Allergic reactions: rash, itching or swelling. - Electrolyte imbalance: disturbances in calcium or phosphate levels. - Anaphylaxis: rare, life‑threatening hypersensitivity.

Before using Moxydar, consider the following safety measures. - Renal impairment: use with caution, monitor magnesium levels. - Children: dosage should be determined by a healthcare professional. - Pregnancy and breastfeeding: consult a physician before use. - Prolonged use: avoid extended therapy without medical supervision. - Concomitant medications: assess potential interactions with other antacids. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Moxydar can affect the absorption or effectiveness of several medicines.

Major Interactions (Avoid): - Tetracycline antibiotics: chelation reduces antibiotic absorption. - Iron supplements: decreased iron uptake. - Potassium chloride: reduced potassium absorption. - Other aluminium or magnesium antacids: risk of overdose. - Digoxin: lowered serum digoxin levels.

Moderate Interactions (Monitor Closely): - Warfarin: possible alteration of INR values. - Levothyroxine: decreased thyroid hormone absorption. - Fluoroquinolone antibiotics: reduced bioavailability. - HIV protease inhibitors: may lower drug concentrations. - Certain antifungal agents: potential decrease in efficacy.